The structural
biology & molecular modeling techniques market is expected to
reach USD 13.1 billion by 2025, according to a new study by Grand View
Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles
has led to an upsurge in the prevalence of chronic diseases, such as diabetes
and cancer, which is presumed to propel the structural biology & molecular
modeling techniques market during the forecast period.
Moreover, increasing drug resistance coupled with the
high drug attrition rate is engendering the requirement for extensive R&D
activities, which is presumed to boost the adoption of structural biology &
molecular modeling techniques in the drug discovery and development process.
This is expected to serve as an efficient approach in fast tracking the development
of drugs with high potency.
The heightening demand for molecular modeling
techniques is predominantly attributable to the significant cost reduction
enabled. This is due to the fact that prediction software identifies possible
adverse reactions and determines drug efficacy and toxicity in the pre-clinical
stages, thereby reducing the probability of drug failure at the later stages.
Consequentially, the aforementioned factors serve as prominent reasons
responsible for the widened market demand.
Browse full research report on Structural Biology & Molecular Modeling Techniques
Market: https://www.grandviewresearch.com/industry-analysis/structural-biology-and-molecular-modeling-technique-market
Further
key findings from the study suggest:
- SaaS & standalone modeling held the largest share of the tools
segment in 2015 owing to extensive utilization of computer-assisted
structuring and modeling techniques in R&D
- The drug discovery segment is anticipated to grow at a lucrative
CAGR owing to continual introduction of software modifications with focus
on enhanced drug designing aimed to accelerate the process in identifying
novel therapeutic agents
- In 2015, North America dominated the global structural biology
& molecular modeling techniques market owing to the presence of a wide
number of established pharmaceutical companies extensively involved in the
commercialization of in silico tools to promote their usage
- Asia Pacific is expected to grow at an exponential CAGR owing to
favorable government initiatives supporting research activities and the
increasing trend of outsourcing drug development by the developed
economies
- The key participants are employing clinical and research
collaborative strategies promoting the adoption of structural prediction
software and databases to gain a competitive advantage
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it
Grand
View Research has segmented the structural biology & molecular modeling
techniques market on the basis of tools, applications, and region:
Tools
Outlook (Revenue, USD Million, 2014 - 2025)
- SaaS &
standalone modeling
- Homology
modeling
- Threading
- Molecular
dynamics
- Ab Initio
- Hybrid
- Others
- Visualization
& analysis
- Databases
- Others
Application
Outlook (Revenue, USD Million, 2014 - 2025)
- Drug
development
- Drug
discovery
- Others
Regional
Outlook (Revenue, USD Billion, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- India
- Latin America
- Mexico
- Brazil
- MEA
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
No comments:
Post a Comment